List of Excipients in API desvenlafaxine succinate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing desvenlafaxine succinate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PRISTIQ | desvenlafaxine succinate | 0008-1211 | CELLULOSE, MICROCRYSTALLINE | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PRISTIQ | desvenlafaxine succinate | 0008-1211 | FERRIC OXIDE RED | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PRISTIQ | desvenlafaxine succinate | 0008-1211 | FERRIC OXIDE YELLOW | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PRISTIQ | desvenlafaxine succinate | 0008-1211 | HYPROMELLOSE 2208 | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PRISTIQ | desvenlafaxine succinate | 0008-1211 | MAGNESIUM STEARATE | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | PRISTIQ | desvenlafaxine succinate | 0008-1211 | POLYETHYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing desvenlafaxine succinate
Detailed excipient profiles for desvenlafaxine succinate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
desvenlafaxine succinate drug variants containing CELLULOSE, MICROCRYSTALLINE
desvenlafaxine succinate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
desvenlafaxine succinate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | desvenlafaxine succinate | 68788-7488 |
| Preferred Pharmaceuticals Inc | desvenlafaxine succinate | 68788-8556 |
| Bryant Ranch Prepack | desvenlafaxine succinate | 71335-1331 |
| >Company | >Ingredient | >NDC |
desvenlafaxine succinate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
desvenlafaxine succinate drug variants containing FERRIC OXIDE RED
desvenlafaxine succinate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
desvenlafaxine succinate drug variants containing FERRIC OXIDE YELLOW
desvenlafaxine succinate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
desvenlafaxine succinate drug variants containing FERROSOFERRIC OXIDE
desvenlafaxine succinate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
desvenlafaxine succinate drug variants containing HYPROMELLOSE
desvenlafaxine succinate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
desvenlafaxine succinate drug variants containing HYPROMELLOSE 2208
desvenlafaxine succinate drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSES
desvenlafaxine succinate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | desvenlafaxine succinate | 68180-592 |
| DIRECT RX | desvenlafaxine succinate | 72189-147 |
| >Company | >Ingredient | >NDC |
desvenlafaxine succinate drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
desvenlafaxine succinate drug variants containing MAGNESIUM STEARATE
desvenlafaxine succinate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
desvenlafaxine succinate drug variants containing POLYETHYLENE GLYCOL
desvenlafaxine succinate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
desvenlafaxine succinate drug variants containing POLYETHYLENE GLYCOL 3350
desvenlafaxine succinate drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 6000
desvenlafaxine succinate drug variants containing POLYETHYLENE GLYCOL 6000
desvenlafaxine succinate drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
desvenlafaxine succinate drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | desvenlafaxine succinate | 63629-7559 |
| Preferred Pharmaceuticals Inc | desvenlafaxine succinate | 68788-7175 |
| Proficient Rx LP | desvenlafaxine succinate | 71205-586 |
| >Company | >Ingredient | >NDC |
desvenlafaxine succinate drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
desvenlafaxine succinate drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | desvenlafaxine succinate | 54868-2932 |
| >Company | >Ingredient | >NDC |
desvenlafaxine succinate drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYVINYL ALCOHOL
desvenlafaxine succinate drug variants containing POLYVINYL ALCOHOL
desvenlafaxine succinate drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K90
desvenlafaxine succinate drug variants containing POVIDONE K90
desvenlafaxine succinate drug variants not containing POVIDONE K90
Excipient focus: SILICON DIOXIDE
desvenlafaxine succinate drug variants containing SILICON DIOXIDE
desvenlafaxine succinate drug variants not containing SILICON DIOXIDE
Excipient focus: TALC
desvenlafaxine succinate drug variants containing TALC
desvenlafaxine succinate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
desvenlafaxine succinate drug variants containing TITANIUM DIOXIDE
desvenlafaxine succinate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
